EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A novel Bayesian generative approach for estimating tumor dynamics from published studies

Arya Pourzanjani iD, Saurabh Modi iD, Jamie Connarn iD, Xinwen Zhang iD, Vijay Upreti iD, Chih-Wei Lin, Khamir Mehta

CPT: Pharmacometrics & Systems Pharmacology · 2024

DOI: 10.1002/psp4.13163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2024. Verfasst von Arya Pourzanjani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology Modeling & Simulation (CPMS) Department, Amgen Inc., South San Francisco, California, USA. Hauptthemen laut MEDLINE: Bayes Theorem, Neoplasms. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor growth inhibition (TGI) modeling attempts to describe the time course changes in tumor size for patients undergoing cancer therapy. TGI models present several advantages over traditional exposure–response models that are based explicitly on clinical end points and have become a popular tool in the pharmacometrics community. Unfortunately, the data required to fit TGI models, namely longitudinal tumor measurements, are sparse or often not available in literature or publicly accessible databases. On the contrary, common end points such as progression‐free survival (PFS) and objective response rate (ORR) are directly derived from longitudinal tumor measurements and are routinely published. To this end, a Bayesian generative model relating underlying tumor dynamics to summary PFS and ORR data is introduced to learn TGI model parameters using only published summary data. The parameterized model can describe the tumor dynamics, quantify treatment effect, and account for differences in the study population. The utility of this model is shown by applying it to several published studies, and learned parameters are combined to simulate an in silico trial of a novel combination therapy in a novel setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bayes TheoremNeoplasmsHumansComputer SimulationProgression-Free SurvivalAntineoplastic AgentsModels, Biological

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Clinical Pharmacology Modeling & Simulation (CPMS) Department, Amgen Inc., South San Francisco, California, USA.
  • Clinical Pharmacology Modeling & Simulation (CPMS) Department, Amgen Inc., Thousand Oaks, California, USA.

ORCID-Profile: Arya Pourzanjani, Saurabh Modi, Jamie Connarn, Xinwen Zhang, Vijay Upreti

Zitieren

APA

Pourzanjani, A., Modi, S., Connarn, J., Zhang, X., Upreti, V., Lin, C. W., & Mehta, K. (2024). A novel Bayesian generative approach for estimating tumor dynamics from published studies. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.13163

Vancouver

Pourzanjani A, Modi S, Connarn J, Zhang X, Upreti V, Lin CW, et al. A novel Bayesian generative approach for estimating tumor dynamics from published studies. CPT: Pharmacometrics & Systems Pharmacology. 2024. doi:10.1002/psp4.13163

BibTeX
@article{Pourzanjani2024,
  author = {Pourzanjani, Arya and Modi, Saurabh and Connarn, Jamie and Zhang, Xinwen and Upreti, Vijay and Lin, Chih-Wei and Mehta, Khamir},
  title = {A novel Bayesian generative approach for estimating tumor dynamics from published studies},
  journal = {CPT: Pharmacometrics & Systems Pharmacology},
  year = {2024},
  doi = {10.1002/psp4.13163}
}
Kostenlos starten →